“Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis”, J of Skin, vol. 2, no. S1, p. S8, Feb. 2018, doi: 10.25251/skin.2.supp.8.